Jag Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Jag Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$194.44 - $217.61 $4,861 - $5,440	25 Added 0.86%	2,943 $576,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $729,760 - $1 Million	-4,000 Reduced 57.82%	2,918 $574,000
Q2 2022 Aug 01, 2022	BUY	$204.13 - $302.4 $1.41 Million - $2.09 Million	6,918 New	6,918 $1.48 Million
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $12.4 Million - $17.5 Million	-48,452 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $455,037 - $581,040	-1,295 Reduced 2.6%	48,452 $18.3 Million
Q3 2021 Oct 21, 2021	BUY	$372.64 - $458.3 $3.64 Million - $4.47 Million	9,758 Added 24.4%	49,747 $20.5 Million
Q2 2021 Jul 23, 2021	BUY	$294.17 - $371.65 $11.8 Million - $14.9 Million	39,989 New	39,989 $14.8 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jag Capital Management, LLC with notifications on news.